
pmid: 25456642
Monitoring of glycemic control is a key component of the diabetes treatment plan. Patients who are not meeting targets often require more intensive monitoring, ranging from frequent self-monitored glucose to continuous glucose monitoring in order to facilitate medication and lifestyle changes. However, more intensive monitoring demands more training and a structured plan for interpretation and use of the data. Better patient and provider tools to support decision-making and progress toward an artificial pancreas may help to alleviate this burden.
Blood Glucose, Glycated Hemoglobin, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Blood Glucose Self-Monitoring, Humans, Hypoglycemic Agents, Insulin, Drug Monitoring, Hypoglycemia
Blood Glucose, Glycated Hemoglobin, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Blood Glucose Self-Monitoring, Humans, Hypoglycemic Agents, Insulin, Drug Monitoring, Hypoglycemia
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
